Ali Shilatifard

Last updated
Ali Shilatifard
Dr. Ali Shilatifard, scientist, biochemist.jpg
Alma mater
SpouseLaura Shilatifard
Children4
AwardsElected member of the American Academy of Arts & Sciences (AAA&S) [1]

Elected Fellow of the American Association for the Advancement of Science (AAAS)

ASBMB-AMGEN Award

Contents

[2]
Scientific career
Institutions

Ali Shilatifard is an American biochemist, molecular biologist, the Robert Francis Furchgott Professor and chairman of the department of biochemistry and molecular genetics, and the director of the Simpson Query Institute for Epigenetics [3] [4] at the Northwestern University Feinberg School of Medicine. He has served as a member of the Senior Editorial Board for the journal Science. [5] He also served as the founding Deputy Editor and the first academic Editor for Science's open access journal Science Advances between 2014 and 2023. [6] During his tenure as the editor of Science Advances, the journal brought onboard roughly 50 deputy editors and over 350 associate editors managing over 22,000 annual submissions and roughly 2,000 annual publications, reaching an impact factor of 14.98. [6] . He has served on the Scientific Advisory Board (SAB) of Keystone Symposia, Max Planck Society, and Genentech and is a member of the jury for the BBVA Foundation Prize in Medicine.

Research in Shilatifard's lab focuses on the cause of childhood leukemia through chromosomal translocations, the role of ELL in this process, and the discovery of the Super Elongation Complex as being a central complex linking MLL translocations into a diverse number of genes to leukemic pathogenesis. He is an elected fellow of the American Association for the Advancement of Science (AAAS), and elected member of American Academy of Arts & Sciences (AAA&S).

Biography

Shilatifard has said he developed his love of science as a young boy working with and observing his grandfather, [7] a physician/scientist and professor of medicine of the University of Tehran. Shilatifard moved to the United States in 1984 where he began his study of organic chemistry at Kennesaw State University in Georgia. He began to work on his doctoral degree in biochemistry at the University of Georgia, Athens. Shilatifard completed his Ph.D. from the University of Oklahoma where his mentor, Dr. Richard Cummings, had moved his program. As a Jane Coffin Childs Postdoctoral Fellow at the Oklahoma Medical Research Foundation, Shilatifard identified the first function of any of the MLL translocation partners found in leukemia [8] and proposed that transcriptional elongation control is central to leukemia pathogenesis. Shilatifard began his independent lab in the Edward A. Doisy Department of Biochemistry and Molecular Biology at the St. Louis University School of Medicine, where he identified the first histone H3 lysine 4 (H3K4) methylase in Saccharomyces cerevisiae : which he named Set1/COMPASS; [9] [10] and defined the pathway of histone H3K4 methylation which is highly conserved from yeast to human. [11] [12] Studies from Shilatifard's laboratory linking epigenetic factors and transcription elongation control to malignancies have provided therapeutic approaches for the treatment of these cancers. [13] [14] [15] He also served on the Life Sciences jury for the Infosys Prize in 2017. On April 12, 2019, Shilatifard presented "Childhood Leukemia: On the Edge of Extinction!" at TEDxUofIChicago. [16]

Related Research Articles

<span class="mw-page-title-main">Histone</span> Family proteins package and order the DNA into structural units called nucleosomes.

In biology, histones are highly basic proteins abundant in lysine and arginine residues that are found in eukaryotic cell nuclei and in most Archaeal phyla. They act as spools around which DNA winds to create structural units called nucleosomes. Nucleosomes in turn are wrapped into 30-nanometer fibers that form tightly packed chromatin. Histones prevent DNA from becoming tangled and protect it from DNA damage. In addition, histones play important roles in gene regulation and DNA replication. Without histones, unwound DNA in chromosomes would be very long. For example, each human cell has about 1.8 meters of DNA if completely stretched out; however, when wound about histones, this length is reduced to about 90 micrometers (0.09 mm) of 30 nm diameter chromatin fibers.

<span class="mw-page-title-main">Histone methyltransferase</span> Histone-modifying enzymes

Histone methyltransferases (HMT) are histone-modifying enzymes, that catalyze the transfer of one, two, or three methyl groups to lysine and arginine residues of histone proteins. The attachment of methyl groups occurs predominantly at specific lysine or arginine residues on histones H3 and H4. Two major types of histone methyltranferases exist, lysine-specific and arginine-specific. In both types of histone methyltransferases, S-Adenosyl methionine (SAM) serves as a cofactor and methyl donor group.
The genomic DNA of eukaryotes associates with histones to form chromatin. The level of chromatin compaction depends heavily on histone methylation and other post-translational modifications of histones. Histone methylation is a principal epigenetic modification of chromatin that determines gene expression, genomic stability, stem cell maturation, cell lineage development, genetic imprinting, DNA methylation, and cell mitosis.

<span class="mw-page-title-main">Histone-modifying enzymes</span> Type of enzymes

Histone-modifying enzymes are enzymes involved in the modification of histone substrates after protein translation and affect cellular processes including gene expression. To safely store the eukaryotic genome, DNA is wrapped around four core histone proteins, which then join to form nucleosomes. These nucleosomes further fold together into highly condensed chromatin, which renders the organism's genetic material far less accessible to the factors required for gene transcription, DNA replication, recombination and repair. Subsequently, eukaryotic organisms have developed intricate mechanisms to overcome this repressive barrier imposed by the chromatin through histone modification, a type of post-translational modification which typically involves covalently attaching certain groups to histone residues. Once added to the histone, these groups elicit either a loose and open histone conformation, euchromatin, or a tight and closed histone conformation, heterochromatin. Euchromatin marks active transcription and gene expression, as the light packing of histones in this way allows entry for proteins involved in the transcription process. As such, the tightly packed heterochromatin marks the absence of current gene expression.

<span class="mw-page-title-main">KMT2A</span> Protein-coding gene in the species Homo sapiens

Histone-lysine N-methyltransferase 2A, also known as acute lymphoblastic leukemia 1 (ALL-1), myeloid/lymphoid or mixed-lineage leukemia1 (MLL1), or zinc finger protein HRX (HRX), is an enzyme that in humans is encoded by the KMT2A gene.

<span class="mw-page-title-main">AFF1</span> Protein-coding gene in the species Homo sapiens

AF4/FMR2 family member 1 is a protein that in humans is encoded by the AFF1 gene. At its same location was a record for a separate PBM1 gene, which has since been withdrawn and considered an alias. It was previously known as AF4.

<span class="mw-page-title-main">ELL (gene)</span> Protein-coding gene in the species Homo sapiens

RNA polymerase II elongation factor ELL is an enzyme that in humans is encoded by the ELL gene.

<span class="mw-page-title-main">WDR5</span> Protein-coding gene in the species Homo sapiens

WD repeat-containing protein 5 is a protein that in humans is encoded by the WDR5 gene.

<span class="mw-page-title-main">KMT2D</span> Protein-coding gene in humans

Histone-lysine N-methyltransferase 2D (KMT2D), also known as MLL4 and sometimes MLL2 in humans and Mll4 in mice, is a major mammalian histone H3 lysine 4 (H3K4) mono-methyltransferase. It is part of a family of six Set1-like H3K4 methyltransferases that also contains KMT2A, KMT2B, KMT2C, KMT2F, and KMT2G.

<span class="mw-page-title-main">ASH2L</span> Protein-coding gene in the species Homo sapiens

Set1/Ash2 histone methyltransferase complex subunit ASH2 is an enzyme that in humans is encoded by the ASH2L gene.

<span class="mw-page-title-main">MLLT1</span> Protein-coding gene in the species Homo sapiens

Protein ENL is a protein that in humans is encoded by the MLLT1 gene.

<span class="mw-page-title-main">Biomarkers of aging</span> Type of biomarkers

Biomarkers of aging are biomarkers that could predict functional capacity at some later age better than chronological age. Stated another way, biomarkers of aging would give the true "biological age", which may be different from the chronological age.

Embryonic stem cells are capable of self-renewing and differentiating to the desired fate depending on their position in the body. Stem cell homeostasis is maintained through epigenetic mechanisms that are highly dynamic in regulating the chromatin structure as well as specific gene transcription programs. Epigenetics has been used to refer to changes in gene expression, which are heritable through modifications not affecting the DNA sequence.

<span class="mw-page-title-main">Enhancer of polycomb homolog 2 (drosophila)</span> Protein-coding gene in the species Homo sapiens

Enhancer of polycomb homolog 2 (Drosophila) is a protein that in humans is encoded by the EPC2 gene.

H3K4me3 is an epigenetic modification to the DNA packaging protein Histone H3 that indicates tri-methylation at the 4th lysine residue of the histone H3 protein and is often involved in the regulation of gene expression. The name denotes the addition of three methyl groups (trimethylation) to the lysine 4 on the histone H3 protein.

<span class="mw-page-title-main">Thomas Jenuwein</span> German scientist

Thomas Jenuwein is a German scientist working in the fields of epigenetics, chromatin biology, gene regulation and genome function.

<span class="mw-page-title-main">Rob Klose</span> Canadian geneticist

Rob Klose is a Canadian researcher and Professor of Genetics at the Department of Biochemistry, University of Oxford. His research investigates how chromatin-based and epigenetic mechanisms contribute to the ways in which gene expression is regulated.

In epigenetics, proline isomerization is the effect that cis-trans isomerization of the amino acid proline has on the regulation of gene expression. Similar to aspartic acid, the amino acid proline has the rare property of being able to occupy both cis and trans isomers of its prolyl peptide bonds with ease. Peptidyl-prolyl isomerase, or PPIase, is an enzyme very commonly associated with proline isomerization due to their ability to catalyze the isomerization of prolines. PPIases are present in three types: cyclophilins, FK507-binding proteins, and the parvulins. PPIase enzymes catalyze the transition of proline between cis and trans isomers and are essential to the numerous biological functions controlled and affected by prolyl isomerization Without PPIases, prolyl peptide bonds will slowly switch between cis and trans isomers, a process that can lock proteins in a nonnative structure that can affect render the protein temporarily ineffective. Although this switch can occur on its own, PPIases are responsible for most isomerization of prolyl peptide bonds. The specific amino acid that precedes the prolyl peptide bond also can have an effect on which conformation the bond assumes. For instance, when an aromatic amino acid is bonded to a proline the bond is more favorable to the cis conformation. Cyclophilin A uses an "electrostatic handle" to pull proline into cis and trans formations. Most of these biological functions are affected by the isomerization of proline when one isomer interacts differently than the other, commonly causing an activation/deactivation relationship. As an amino acid, proline is present in many proteins. This aids in the multitude of effects that isomerization of proline can have in different biological mechanisms and functions.

H3K4me1 is an epigenetic modification to the DNA packaging protein Histone H3. It is a mark that indicates the mono-methylation at the 4th lysine residue of the histone H3 protein and often associated with gene enhancers.

Set1 is a gene that codes for Histone-lysine N-methyltransferase and H3 lysine-4 specific proteins (H3K). Set1 proteins can also be referred to as COMPASS proteins. The first H3K4 methylase, Saccharomyces cerevisiae Set1/COMPASS, is highly conserved across a multitude of phylogenies. The histone methylation facilitated by Set1 is required for cell growth and transcription silencing through the repression of RNA polymerase II. The Set1C, COMPASS Complex, also aids in transcription elongation regulation and the maintenance of telomere length.

References

  1. Dimmer, Olivia. "Four Feinberg Faculty Elected to American Academy of Arts and Sciences" . Retrieved 30 May 2017.
  2. Pinholster, Ginger. "2016 AAAS Fellows Honored for Advancing Science to Serve Society". AAAS. Retrieved 21 April 2023.
  3. "Northwestern Receives $10 Million for Epigenetics Center". Philanthropy News Digest. Foundation Center. Retrieved 9 February 2018.
  4. Di Mento, Maria. "Netflix Co-Founder Reed Hastings Gives $1 Million to Improve Policing (Gifts Roundup)". The Chronicle of Philanthropy. Retrieved 11 June 2020.
  5. "Ali Shilatifard, Ph.D. | Science". Science. 9 Jan 2024.
  6. 1 2 Shilatifard, Ali (2023-12-15). "For the love of Science…Advances". Science Advances. 9 (50). doi:10.1126/sciadv.adn1134. ISSN   2375-2548. PMC   10718484 . PMID   38091403.
  7. Ali Shilatifard: Discovering the roots of cancer, St. Louis Business Journal, Jul 23, 2006
  8. Shilatifard, A; Lane, WS; Jackson, KW; Conaway, RC; Conaway, JW (March 1996). "An RNA polymerase II elongation factor encoded by the human ELL gene". Science. 271 (5257): 1873–6. Bibcode:1996Sci...271.1873S. doi:10.1126/science.271.5257.1873. PMID   8596958. S2CID   46101044.
  9. Miller, T.; et al. (2001). "COMPASS: a complex of proteins associated with a trithorax-related SET domain protein". Proc Natl Acad Sci U S A. 98 (23): 12902–12907. Bibcode:2001PNAS...9812902M. doi: 10.1073/pnas.231473398 . PMC   60797 . PMID   11687631.
  10. Krogan, N. J.; et al. (2002). "COMPASS, a histone H3 (Lysine 4) methyltransferase required for telomeric silencing of gene expression". J Biol Chem. 277 (13): 10753–10755. doi: 10.1074/jbc.C200023200 . PMID   11805083.
  11. Smith, E.; Shilatifard, A. (2010). "The chromatin signaling pathway: diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes". Mol Cell. 40 (5): 689–701. doi:10.1016/j.molcel.2010.11.031. PMC   3037032 . PMID   21145479.
  12. Lee, J. S.; et al. (2007). "Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS". Cell. 131 (6): 1084–1096. doi: 10.1016/j.cell.2007.09.046 . PMID   18083099. S2CID   11783020.
  13. Piunti, Andrea; Hashizume, Rintaro; Morgan, Marc A; Bartom, Elizabeth T; Horbinski, Craig M; Marshall, Stacy A; Rendleman, Emily J; Ma, Quanhong; Takahashi, Yoh-hei; Woodfin, Ashley R; Misharin, Alexander V; Abshiru, Nebiyu A; Lulla, Rishi R; Saratsis, Amanda M; Kelleher, Neil L; James, C David; Shilatifard, Ali (2017). "Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas". Nature Medicine. 23 (4): 493–500. doi:10.1038/nm.4296. PMC   5667640 . PMID   28263307.
  14. Liang, Kaiwei; Volk, Andrew G; Haug, Jeffrey S; Marshall, Stacy A; Woodfin, Ashley R; Bartom, Elizabeth T; Gilmore, Joshua M; Florens, Laurence; Washburn, Michael P; Sullivan, Kelly D; Espinosa, Joaquin M; Cannova, Joseph; Zhang, Jiwang; Smith, Edwin R; Crispino, John D; Shilatifard, Ali (2017). "Therapeutic Targeting of MLL Degradation Pathways in MLL-Rearranged Leukemia". Cell. 168 (1–2): 59–72.e13. doi:10.1016/j.cell.2016.12.011. PMC   5351781 . PMID   28065413.
  15. Wang, Lu; Zhao, Zibo; Ozark, Patrick A.; Fantini, Damiano; Marshall, Stacy A.; Rendleman, Emily J.; Cozzolino, Kira A.; Louis, Nundia; He, Xingyao (2018-05-21). "Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy". Nature Medicine. 24 (6): 758–769. doi:10.1038/s41591-018-0034-6. ISSN   1546-170X. PMC   6055231 . PMID   29785026.
  16. "TEDxUofIChicago". ted.com. Retrieved 3 June 2019.